Peer-reviewedCC BYBiomedicines
Management of Hip Instability in Spinal Muscular Atrophy in the Disease-Modifying Therapy Era: The “Late Autumn” or “Early Spring” of Neuro-Orthopedics?
- 1H. Turner National Medical Research Center for Children’s Orthopedics and Trauma Surgery, Parkovaya 64–68, Pushkin, 196603 Saint Petersburg, Russia
- 2National Medical Research Center of Children’s Health, Lomonosovsky Avenue, 2 Building 1, 119991 Moscow, Russia
Related
- Paediatric palliative approach in the era of disease modifying therapies in spinal muscular atrophy — a comprehensive landscape of French specialist physicians’ perspectives
- Defining the clinical benefits of disease-modifying therapy in people living with spinal muscular atrophy who require permanent ventilation: a UK-based modified Delphi consensus process
- Computational identification and experimental validation of early glycinergic impairments in spinal muscular atrophy
- Prevalence of Hypovitaminosis D and Its Association with Motor Impairment in Spinal Muscular Atrophy
- CCN1-mediated stress signaling underlies intrinsic cardiomyocyte dysfunction in spinal muscular atrophy
BibTeX
@article{kenis2026management,
title = {{Management of Hip Instability in Spinal Muscular Atrophy in the Disease-Modifying Therapy Era: The “Late Autumn” or “Early Spring” of Neuro-Orthopedics?}},
author = {Vladimir Kenis and Alexey Kurenkov},
journal = {Biomedicines},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13702002},
note = {CC BY},
}
RIS
TY - JOUR
TI - Management of Hip Instability in Spinal Muscular Atrophy in the Disease-Modifying Therapy Era: The “Late Autumn” or “Early Spring” of Neuro-Orthopedics?
AU - Vladimir Kenis
AU - Alexey Kurenkov
PY - 2026
DA - 2026/09/22
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13702002
SN - 2227-9059
ER -